Miguel Petrozzi
Neurology · Brownsville, TXNPI 1366587727
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.4% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for neurology clinicians in TX, where the typical reported total is $2,170.
Across 98 payments — averaging $32.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$649
- UCB, Inc.$633
- Neurelis, Inc.$581
- Immedica Pharma US, Inc.$166
- Livanova USA, Inc.$149
- Eisai Inc.$136
- plus $836 from 18 others
What the payments were for
- Food & beverage$2,84790%
- Education$30310%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 13 | $649 |
| UCB, Inc. | 21 | $633 |
| Neurelis, Inc. | 20 | $581 |
| Immedica Pharma US, Inc. | 3 | $166 |
| Livanova USA, Inc. | 1 | $149 |
| Eisai Inc. | 6 | $136 |
| Biomarin Pharmaceutical Inc. | 2 | $130 |
| Jazz Pharmaceuticals Inc. | 4 | $125 |
| Greenwich Biosciences, Inc. | 3 | $92 |
| Otter Pharmaceuticals, LLC | 3 | $79 |
| ITF Therapeutics LLC | 2 | $66 |
| Genentech USA, Inc. | 3 | $54 |
| Sarepta Therapeutics, Inc. | 3 | $53 |
| Shire North American Group Inc | 3 | $45 |
| Corium, LLC | 2 | $27 |
| Biocodex, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Pyros Pharmaceuticals, Inc. | 1 | $21 |
| Zogenix Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| SK Life Science, Inc. | 1 | $17 |
| Springworks Therapeutics, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Strongbridge US Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$149
- ZTALMY$134
- SPINRAZA$120
- Fintepla$109
How this compares
$3,150 in reported general payments places this provider in the 50th percentile of 1,246 neurology providers in Texas.
Other neurology in Brownsville
- Ann BassSan Antonio$1.7M
- William OndoHouston$1.4M
- Nirav PavasiaDallas$1.4M
- Mirla AvilaLubbock$1.3M
- Michael SoileauGeorgetown$1.2M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Benjamin GreenbergDallas$773K
- Annette OkaiPlano$730K
- Waleed El-FekyDallas$587K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.